CDMO企业药明生物收购龙沙在华生物制药厂，加速布局亚太市场——Fierce Pharma报道
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
#CDMO Joinn#Joinn Biologics#China biologics#Fierce Pharma#Biologics snaps
生命科学资讯
生物技术与制药领域的最新动态
JPM 2025：龙沙集团分享CHI退出与收购战略展望——聚焦制药技术领域
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
#Lonza shares#Pharmaceutical Technology#CHI exit#Technology JPM#shares outlook